Tax Policy
In response to the international trend in tax governance, the compliance of tax laws and regulations, the realization of sustainable corporate development, the enhancement of shareholder value, and the fulfillment of social responsibilities and tax obligations, Diamond Biofund formed the Tax Governance Policy in October 2024, which has been announced and implemented after approval by the chairman. The Company and subsidiaries included in the consolidated financial statements comply with the above Tax Governance Policy in the course of handling various tax affairs.
Tax Governance Policy
Tax Information
100% of the operating revenue, profit (loss) before income tax, and income tax expense of Diamond Biofund in 2023 were generated from operations in Taiwan.
Country |
Major Business Items |
Number of Employees |
Operating Revenue |
Profit (Loss) before Income Tax |
Income Tax Paid |
Income Tax Expense (Benefit) |
Taiwan |
Venture capital |
21 |
(2,439,518) |
(2,583,823) |
0 |
(412) |
Tax Information for Two Year
Item |
2022 |
2023 |
|
Profit (Loss) before Income Tax (A) |
881,121 |
(2,583,823) |
|
Income Tax Expense (Benefit) (B) |
83,340 |
(412) |
|
Effective Tax Rate % (C) = (B)/(A) |
9.46% |
0.02% |
|
Adjustments (D) |
Timing difference |
0 |
0 |
Tax-exempt income |
0 | 0 | |
Effective Tax (E)=(B)+(D) |
83,340 |
(412) |
|
Effective Tax % (E)/(A) |
9.46% |
0.02% |
|
Income Tax Paid (F) |
105,640 |
82,849 |
|
Cash Tax Rate (F)/(A) |
11.99% |
-3.21% |
Note: The above tax information is based on the audited financial statements of Diamond Biofund for 2022 and 2023, as detailed on pages 6, 8 and 29。